Background Existing studies of the quality of tuberculosis care have relied on recall-based patient surveys, questionnaire surveys of knowledge, and prescription or medical record analysis, and the results mostly show the health-care provider's knowledge rather than actual practice. No study has used standardised patients to assess clinical practice. Therefore we aimed to assess quality of care for tuberculosis using such patients.
Introduction
India accounts for a quarter of the 9 million estimated cases of tuberculosis that occur worldwide, and for 1 million of the 3 million missing cases (ie, undiagnosed or not reported to tuberculosis control programmes). 1 India's tuberculosis burden is exacerbated by fragmented provision of health care through diverse providers, and an unregulated private sector that accounts for half of the provision of tuberculosis treatment. 2, 3 The private sector includes qualifi ed allopathic doctors (eg, Bachelor of Medicine and Surgery [MBBS] degree), practitioners of alternative health systems (eg, ayurveda), and informal providers with few or no formal qualifi cations.
Data from India have raised concerns about the poor quality of medical care in general. [4] [5] [6] [7] Results of a systematic review 8 showed that in most Indian studies, less than half of providers knew to order sputum microscopy tests for patients with symptoms of tuberculosis, and less than a third knew the correct treatment regimen. Adherence to International Standards for Tuberculosis Care (ISTC) was signifi cantly lower in the private sector than in the public sector. 8 Results of studies about patient pathways for tuberculosis have shown convoluted paths, 9 with patients seeing a median of three health-care providers (range 2-12) over a median of 55 days (IQR 47-62) from onset of symptoms to diagnosis and treatment. 10 Studies of quality of tuberculosis care in India and elsewhere have relied on recall-based patient surveys, questionnaire surveys of knowledge, and analysis of prescription and chart records, 8 but these methods might not be an accurate representation of actual practice. 4, 6, [11] [12] [13] [14] Consequently, standardised patients-ie, people who have been trained to portray, in a standardised way, patients in a medical situation-are increasingly used in low-income countries to assess quality of medical care, as shown by studies from India and China. 5, 6, 13 By comparison with other methods, data from standardised patients yield an assessment of provider practice that is free from observation bias, are less susceptible to recall bias than patient exit interviews, and are more complete than medical records. 14, 15 Furthermore, standardised patients enable estimation of case-detection rates because illnesses are fi xed by design. Finally, because case presentations are standardised, the standardised-patient method enables valid quality comparisons to be made across diff erent types of health-care providers. We therefore did a pilot validation study of the standardisedpatient method to assess the quality of tuberculosis care in the private sector in New Delhi.
Methods

Study design and participants
This pilot, cross-sectional study was done in Delhi. In an urban setting, the risk of detecting standardised patients is small because many patients are unknown to health-care providers. Apparently healthy individuals were recruited to be standardised patients, and intensively screened and trained for 3 weeks. These standardised patients included both individuals who had participated in previous studies and new recruits. A convenience sample of 106 private health-care providers practising in outpatient settings was recruited in lowincome and middle-income areas of Delhi. High-income areas were excluded. All recruited providers were informed that over the subsequent 6 months they might receive someone who is not a real patient, and if they suspected any of their patients to not be genuine, they should record the name of the patient and date of the visit. We randomly allocated standardised patients to providers stratifi ed by case and sex, using Stata analysis software (version 13 [StataCorp, TX, USA]). Within 1 h of each interaction between the standardised patient and health-care provider, we used a structured questionnaire to extract information from the standardised patient about what each provider had done.
We obtained ethical approvals from McGill University in Montreal, and the Institute of Socio-Economic Research on Development and Democracy (ISERDD) in Delhi. Written informed consent was obtained from all recruited providers (including the use of audio recorders), and confi dentiality was assured. No consent was required for standardised patients because they were employees. The questionnaires, case scripts, checklists, and vignettes are available from the authors on request.
Procedures
We developed four tuberculosis tracer scenarios (cases; table 1; appendix ) with a group of international and Indian experts on tuberculosis, using the Standards for Tuberculosis Care in India (STCI) as the benchmark. 16 The STCI itself is based on the ISTC. 17 Although many standards exist, the expert group focused on the most important aspects of detection and treatment of tuberculosis, and helped to put together case-specifi c checklists of essential and recommended treatments (ie, the expected See Online for appendix
Research in context
Evidence before this study We did a systematic review of PubMed, Embase, and the Web of Science with the search terms "tuberculosis", "knowledge", "practice", "health-care providers", and "India", with no language restrictions, for studies published between January, 2000, and September, 2014. We found that in most studies in India, less than half of health-care providers knew to order sputum microscopy tests for patients with symptoms of tuberculosis, and less than a third knew the correct treatment regimen for this disease. Additionally, the quality of care for patients with suspected or confi rmed tuberculosis was worse in the private sector than in the public sector. Existing studies of quality of tuberculosis care in India and elsewhere have relied on recall-based patient surveys, questionnaire surveys of knowledge, and analysis of prescription or medical records. No study has used standardised (simulated) patients to assess actual clinical practice.
Added value of this study
Our study is the fi rst assessment of quality of care for tuberculosis using the standardised-patient method. The results suggest that this method can be successfully implemented for tuberculosis. Our pilot data suggest low adherence of providers to established standards of tuberculosis care in clinical practice despite markedly high levels of knowledge. correct case management; table 1). The scenarios roughly outlined the pathways for tuberculosis care in the country. The medical representations of the tracer scenarios were further enhanced with the psychosocial aspects of tuberculosis presentation in the community. These socalled tuberculosis scripts were developed by social scientists with the help of the recruited standardised patients to make the diagnosis as obvious and uncomplicated as possible. For instance, in the case of standardised patient 1, appropriate questioning would reveal that the patient has had a cough for 2-3 weeks, produces sputum, has fever with night sweats, and has lost appetite and weight. According to STCI, this should lead the provider to suspect tuberculosis and order appropriate microbiological tests or refer the patient for tuberculosis testing. All scripts were translated into Hindi, the vernacular language. Script development and standardisedpatient training methods are described in the appendix. All standardised patients paid the providers their usual fee.
Implications of all the available evidence
We assessed quality of care through health-care providers' adherence to case-specifi c checklists of recommended care, the appropriateness of treatment, and the use of unnecessary or contraindicated treatments (eg, steroids). The checklists for recommended care include only items that can be completed in low-resource settings and are in accord with the STCI. 16 The list of recommended questions, and the subset that was regarded as essential, are in the appendix. Additionally, we obtained data about the duration and cost of the consultation, and medicines for each interaction. Costs were calculated in 2014 Indian rupees and 2014 US dollars (rate, 1 US dollar=62·27 Indian rupees). Purchasing-powerparity adjustment would result in an exchange rate of 16·76 rupees per dollar. Costs were the fee paid at the time of the interaction to the provider plus prices for medicines and did not include laboratory tests or other fees for procedures that standardised patients did not complete. Finally, the interactions recorded with digital recorders by randomly selected (with Stata version 13) standardised patients were used to assess accuracy of patient recall, measured using a structured recall questionnaire. 18 3-4 weeks after the completion of standardised-patient visits, we visited the participating providers and asked whether they suspected any fake patients at their clinics, and if so, to describe the presenting symptoms, age, and sex of the suspected standardised patient. These data were used to assess detection rates. Additionally, providers were tested using a medical vignette that described exactly the same case scenario as standardised patient 1 (2-3 weeks of cough). The vignette started with the opening statement from standardised patient 1, and the provider was asked to proceed exactly as they might with a real patient. This vignette was used to assess knowledge of diagnosis and treatment for standardised patient 1 and to compare the providers' knowledge in the vignette with what they did in practice with the standardised patient.
Outcomes
The key objective was to validate the standardisedpatient method for assessing the quality of tuberculosis care in the private sector using three criteria: negligible risk and ability to avoid adverse events for providers and standardised patients, low detection rates of standardised patients by providers, and data accuracy across standardised patients and audio verifi cation of standardised patient recall.
Statistical analysis
After the data were compiled, the list of labelled medicines and prescriptions given by the health-care providers to the standardised patients were coded by two doctors with expertise in tuberculosis (SS) and infectious diseases (RS) working independently of one another, who then identifi ed drugs as anti tuberculosis drugs, antibiotics Classic case of presumed tuberculosis in a patient who has had 2-3 weeks of cough and fever and a history of taking a broad-spectrum antibiotic (amoxicillin) for 1 week, given by another health-care provider, with no improvement
Presents after an initial, failed (empirical) treatment for symptoms with broad-spectrum antibiotics
Recommendation for sputum testing, chest radiograph, or referral to a public DOTS centre or qualifi ed provider Standardised patient 3
Chronic cough with a positive sputum smear report for tuberculosis from a public health facility Chronic cough, a positive sputum smear report for tuberculosis from a public health facility, and, if asked, a history of previous, incomplete treatment for tuberculosis, which would raise the suspicion of multidrug-resistant tuberculosis.
Presents as a previously treated patient with tuberculosis with recurrence of the disease (ie, suspicion of drug resistance)
Recommendation for any drug-susceptibility test (culture, line probe assay, or Xpert MTB/RIF) or referral to a public DOTS centre or a specialist
DOTS=directly observed treatment, short-course. (other than tuberculosis drugs), or steroids. Among the antibiotics, we specifi cally coded fl uoroquinolones as a distinct category, in view of their ability to mask underlying tuberculosis. We did not code other drug classes (eg, bronchodilators or cough suppressants) that had been prescribed or dispensed because they had no direct bearing on tuberculosis care. We employed two independent pharmacists to identify any loose, unlabelled pills that had been given to the standardised patients, and on the basis of their assessments we identifi ed whether the medicines included at least one antibiotic. Because chemical analysis is expensive and could not be done, we report the proportion of interactions in which an antibiotic was used in labelled and unlabelled pills separately. We used logistic regression to assess associations between provider qualifi cations and various components of case management for all four standardised patient cases combined. These components included the following: an overall index of correct case management aggregated across all cases; individual components of case management (referrals for all cases, recom mendations for chest radiographs, or sputum tests for standardised patients 1 and 2, and initiation of tuberculosis treatment for standardised patients 3 and 4); and the use of antibiotics and fl uoroquinolones for all cases. We report results as adjusted odds ratios (ORs) for MBBS-qualifi ed versus non-MBBS-qualifi ed providers (rationale in the appendix). All regression models included the age and sex of the provider, the number of real patients waiting at the time when the standardised patient entered the clinic (as an index of patient caseload), and standardised patient and case fi xed-eff ects. Additional specifi cations with standardised patients' age, sex, height, and weight as independent variables instead of the case fi xed-eff ects are in the appendix. We used both t tests and logistic regression to assess the gap between provider knowledge elicited through medical vignettes for standardised patient 1 and provider practice measured with all standardised patients. The diff erences are the result of t tests comparing the vignette performance with the standardised-patient performance for each item as a percentage or total diff erence. Some diff erences are Cost of consultation and medicines combined (Indian rupees)*
Cost of consultation and medicines combined (US dollars)* Number of medicines given or prescribed
Data are mean (95% CI) or n (%, 95% CI). *2014 costs. †Defi ned as a chest radiograph, sputum test, or referral (for standardised patients 1 and 2), isoniazid, rifampicin, pyrazinamide, and ethambutol (the HRZE regimen), or referral (for standardised patient 3), and a drug-susceptibility test, GeneXpert, or referral (for standardised patient 4). ‡Labelled antibiotic use is a lower bound estimate because only identifi ed drugs were included. Any antibiotic use also includes cases for which an unlabelled medicine was identifi ed as an antibiotic by chemists who were specifi cally recruited to identify unlabelled medicines. 
Role of the funding source
The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The fi rst author and corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
Between Feb 2, and March 28, 2014, we screened 22 individuals and randomly assigned 17 as standardised patients across 100 health-care providers for a total of 250 interactions (appendix). Six providers were kept as reserves. The interactions took place between April 1 and April 23, 2014. 97 (97%) of 100 providers were male with a mean age of 47 years (SD 10·37, range 22-75). 29 (29%) had an MBBS degree (qualifi ed allopathic doctors), 40 (40%) held degrees in alternative systems of medicine, and the remaining 31 (31%) were informal health-care providers with few or no qualifi cations. A mean of 1·27 patients (SD 2·25) were waiting in the clinic at the time of the standardised-patient visit.
93 providers completed the detection survey and participated in 232 of the 250 interactions (we obtained survey data between May 22 and June 13, 2014).
Eight providers reported 11 (5%) detections. Of the 11 detections, seven were reported to have occurred during the visit, although in none of the cases did the provider voice suspicion during the interaction with the standardised patient, and four were reported after the completion of the interaction, mainly because the standardised patient did not return for follow-up. In 14 (6%) of 232 cases, providers mistook real patients to be standardised patients. None of the 93 providers who completed the detection survey voiced concern that participation in the study adversely aff ected them. Additionally, no fi nancial losses were incurred by providers because the standardised patients paid normal fees to receive services, and there were no added inconveniences to the provider because standardised patients were trained to immediately step aside if an emergency occurred in the clinic that demanded the provider's attention. None of the 17 standardised patients had any threats to their safety. 129 interactions were recorded by six randomly selected standardised patients. Data from the audio record ings were highly correlated with data from the structured recall questionnaires (r=0·63, 95% CI 0·53-0·79).
The mean standardised-patient interaction lasted 6 min, with a mean payment of 140·71 rupees (95% CI Data are n (%) or mean (SD), unless otherwise specifi ed. Percentages represent the proportion of providers who did that item during a standardised-patient visit or vignette. Although standardised patients 3 and 4 both had laboratory reports that microbiologically confi rmed a diagnosis of tuberculosis, a large proportion of these patients were recommended chest radiographs (table 2) . The proportion of cases that were correctly managed was highest for standardised patient 3, with seven (14%, 7-26) of 50 started on tuberculosis treatment and 13 (26%, referred to the directly observed treatment short-course (DOTS) centre or qualifi ed providers, but the proportion referred to a DOTS centre or a qualifi ed provider fell to ten (20%, 11-33) of 50 for standardised patient 4, showing both the low use of drug-susceptibility tests that are necessary for investigations of a patient with recurrent tuberculosis, and low referrals to the public sector. The low proportions of correct case management are also partly a result of the low use of essential and recommended actions (fi gure 1; appendix). In the case of standardised patient 1, for instance, although most providers asked about cough duration, auscultated the chest, and measured temperature, few checked weight or blood pressure and few asked about blood in their sputum.
Individual pathways to diagnosis and treatment were complex. The diff erent actions that the four standardised-patient cases encountered are in the appendix. Broad-spectrum antibiotics were widely given for standardised patients 1 and 2; fl uoroquinolones were used in at least 10-16% of all cases, and steroids in at least 13% of all interactions for standardised patient 2. The proportions of referrals were higher for standardised patients 3 and 4, but the use of antibiotics for both cases and initiation of tuberculosis treatment for standardised patient 4 were lower than for standardised patients 1 and 2 (table 2). Of the seven tuberculosis drug prescriptions that were given for standardised-patient-3 interactions, six were correct regimens. Of all medicines that were dispensed in the clinic, 607 (54%) of 1118 were loose, unlabelled pills and therefore could not be coded.
Figure 2 and table 3 shows that MBBS-qualifi ed providers were more likely to correctly manage standardised-patient cases than were non-MBBS providers, although they were less likely to refer but not signifi cantly so. For standardised patients 1 and 2, MBBS doctors were more likely to order chest radio graphs and sputum tests. They were, however, equally likely to prescribe broad-spectrum antibiotics and were more likely to prescribe fl uoroquinolones than were non-MBBS providers (fi gure 2, table 3).
Disaggregating by standardised-patient cases suggests that any advantage conferred by an MBBS quali fi cation was most marked for standardised patient 1, for whom recommendation of chest radiographs and sputum tests were negligible from non-MBBS-qualifi ed doctors, but the correct treatment advantage was also present for standardised patients 2 and 3 (data not shown). For standardised patient 4, MBBS providers were less likely to correctly treat the patient because they were more prone to starting tuberculosis treatment rather than referring the standardised patient or recommending drug-susceptibility testing (fi gure 2). Finally, provider age, sex, and the number of patients waiting at the time of the arrival of the standardised patient were not signifi cantly associated with correct case management or the use of antibiotics (data not shown).
69 providers both received a standardised-patient-1 case and completed the vignettes. Provider performance in the vignettes was markedly more consistent with STCI than with the standardised-patient test, with a signifi cantly higher proportion ordering chest radiographs and sputum tests during the vignette (table 4). The proportion of providers questioning the production of sputum or blood in sputum were also higher in vignettes; however, both in vignettes and in practice providers were equally unlikely to ask about any past occurrence of tuberculosis or family history of the disease. Notably, referrals were signifi cantly lower for standardised patients than for vignettes (table 4).
Discussion
Our study, the fi rst assessment of quality of care for tuberculosis using the standardised-patient method, builds on similar research by our team members for other health conditions. 5, 6 Our results suggest that the standardised-patient method can be successfully implemented for tuberculosis-the detection rate in our study compares well with detection rates of 0-25% (mean of 15%) in other standardised-patient studies, including those from India, and could be further reduced by increasing the study duration. 5, 6, 19 India has the world's highest tuberculosis burden, and multidrug-resistant tuberculosis is a growing threat. 20, 21 In recognition of this problem, the Revised National Tuberculosis Control Program has formulated an ambitious national strategic plan , with the goal of universal access to quality tuberculosis diagnosis and treatment for all patients with tuberculosis in the community. 22 This goal is consistent with the End Tuberculosis Strategy by WHO, which emphasises patient-centred care and engagement of all providers. 23 Because the private sector is a major provider of health care, 2, 3, 24 to know how private providers manage tuberculosis in their practice, and factors associated with suboptimal care, is important. 25 Such information is essential for designing public-private mix interventions.
In our study, no risks to either providers or standardised patients were apparent, and recall by standardised patients compared well with audio recordings. Thus, future iterations of this method might help tuberculosiscontrol programmes to design monitoring and assessment indicators for quality of tuberculosis care.
However, our study had limitations. It was a pilot study, designed to validate the use of standardised patients in a sample of consenting private providers; there fore, a random or comprehensive sample of providers was not the goal. The ideal population of providers would be a random sample of providers from both private and public sectors, and would cover diverse areas, in view of the geographical variation in quality of care in India. [4] [5] [6] 11 A second disadvantage, inherent in the standardisedpatient approach, is that data should be analysed in the same manner that it is obtained. This limitation is noticeable in our analysis of drugs dispensed: because 54% of all pills were unlabelled (loose) drugs, we were unable to conclusively assess the amount of antibiotic and steroid use in such cases. Standardised patients were instructed to not ask about the nature of the pills, because this is not consistent with typical patient behaviour, and increases detection risk. We attempted to identify these unlabelled drugs through local pharmacists, but in the absence of chemical analysis, their identifi cation cannot be substantiated. Chemical analysis of pills is possible, but expensive. This is a limitation in any context in which unidentifi ed pills are given to patients, and prescription of unidentifi ed pills, by itself, suggests poor quality of medical care. Although the unlabelled medicines were highly unlikely to be antituberculosis drugs, our estimates of antibiotic and steroid use represent the lower bounds of their actual use in the population.
Our standardised patients did not have physical signs (eg, crackles) that could be identifi ed by chest auscultation, and providers might have been misled by the absence of physical fi ndings. We analysed data separately for providers who undertook auscultation and those who did not for standardised patients 1 and 2 and were unable to detect systematic diff erences in their behaviour (data not shown).
The standardised-patient method works well with one-time and new patient interactions, as opposed to many visits to the same provider or the use of patients who are already known to the doctor. In 190 (76%) of all 250 interactions with standardised patients, the provider asked the patients to come back if they did not get better or to come back with the recommended test results. However, our standardised patients did not return because this would have increased the risk of detection, and case scenarios would have become more complex and less standardised.
The interviews with providers for the detection survey showed a potential pathway whereby providers try out a cocktail of drugs for 1 week to 10 days and, if the patient does not improve, move on to a diff erent set of drugs and ultimately chest radiographs and sputum tests. The standardised-patient-2 case was specifi cally designed to assess this pathway because patients might visit new providers rather than return to the original doctor. 9 However, the proportions of sputum tests and chest radiographs for standardised patient 2 were low and indistinguishable from the proportion for standardised patient 1. A design with repeated standardised-patient visits might therefore produce new insights; such a study, although challenging, could be worth pursuing in the future.
Despite these limitations, our results support those from several Indian studies, 8 using tests of knowledge or prescription practices that show low adherence among private providers to recommended standards, and highly variable practices among providers.
Our study also raises policy-relevant issues. First, informal providers are widely believed to contribute to poor diagnosis and treatment. 9, 26 We did note important diff erences in diagnoses between MBBS-qualifi ed providers and non-MBBS providers, with the non-MBBS providers less likely to order either sputum tests or chest radiographs for standardised patients 1 and 2. However, overall rates of laboratory investigations were low for both groups: even among MBBS-qualifi ed providers, sputum tests were ordered in only eight (11%, 95% CI 6-21) of 71 interactions (appendix), and a drug-susceptibility test was never ordered for the suspected multidrug-resistant case. Contrary to concerns about the use of unnecessary laboratory tests in the private sector, our data suggest that people with symptoms of tuberculosis in India might be severely undertested, although repeat visits by standardised patients will be necessary to better under stand this occurrence. Furthermore, our data suggest that non-MBBS-qualifi ed providers do not seem to prescribe tuberculosis drugs, even for standardised-patient-3 and standardised-patient-4 cases (appendix). Also, no providers used the serological tests to diagnose tuberculosis that were banned in 2012 because they have little accuracy.
Our data also cast doubt about the hypothesis that insuffi cient knowledge and capacity constraints are the limiting factors in the accurate diagnosis and treatment of tuberculosis, and suggest a big gap between knowledge and action-the so-called know-do gap. Doctors seemed to be unaware of key requirements (on vignettes), such as asking about past history of tuberculosis or about Xpert MTB/RIF testing, but many did know about sputum testing and chest radiographs, yet did not order them in practice. We are doing additional work to substantiate our pilot data, understand the know-do gap in provider behaviour, and identify the best approach to measure and improve quality of tuberculosis care in India.
